SARA ROYSE: Open Payments
NPI 1013463918 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,606 in 79 payments from 15 companies in 2025. Trend: 2023 $1,908 · 2024 $1,713 · 2025 $1,606
Food & beverage: $1,412Education: $194
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $364 |
| ABBVIE INC. | 29 | $334 |
| Incyte Corporation | 2 | $153 |
| Amgen Inc. | 1 | $148 |
| Novartis Pharmaceuticals Corporation | 10 | $140 |
| LEO Pharma Inc. | 4 | $93 |
| GENZYME CORPORATION | 4 | $91 |
| Hill Dermaceuticals, Inc. | 3 | $87 |
| UCB, Inc. | 2 | $60 |
| PFIZER INC. | 2 | $32 |
Products named: TREMFYA, SKYRIZI, OPZELURA, OTEZLA, RINVOQ, DUPIXENT, COSENTYX, Tolak.
Industry payments across AZ — which companies pay providers there.
